BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 18775779)

  • 21. Phyllanthin and hypophyllanthin inhibit function of P-gp but not MRP2 in Caco-2 cells.
    Sukhaphirom N; Vardhanabhuti N; Chirdchupunseree H; Pramyothin P; Jianmongkol S
    J Pharm Pharmacol; 2013 Feb; 65(2):292-9. PubMed ID: 23278697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ezrin and radixin both regulate the apical membrane localization of ABCC2 (MRP2) in human intestinal epithelial Caco-2 cells.
    Yang Q; Onuki R; Nakai C; Sugiyama Y
    Exp Cell Res; 2007 Oct; 313(16):3517-25. PubMed ID: 17825285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between human multidrug resistance related protein (MRP2; ABCC2) and excipients commonly used in self-emulsifying drug delivery systems (SEDDS).
    Li L; Yi T; Lam CW
    Int J Pharm; 2013 Apr; 447(1-2):192-8. PubMed ID: 23462368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
    Dahan A; Sabit H; Amidon GL
    Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MK571 inhibits phase-2 conjugation of flavonols by Caco-2/TC7 cells, but does not specifically inhibit their apical efflux.
    Barrington RD; Needs PW; Williamson G; Kroon PA
    Biochem Pharmacol; 2015 Jun; 95(3):193-200. PubMed ID: 25801004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of in vitro Mrp2 transporter model based on intestinal organoids.
    Zhang L; Liang C; Xu P; Liu M; Xu F; Wang X
    Regul Toxicol Pharmacol; 2019 Nov; 108():104449. PubMed ID: 31449916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efflux of baicalin, a flavone glucuronide of Scutellariae Radix, on Caco-2 cells through multidrug resistance-associated protein 2.
    Akao T; Hanada M; Sakashita Y; Sato K; Morita M; Imanaka T
    J Pharm Pharmacol; 2007 Jan; 59(1):87-93. PubMed ID: 17227625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of 5 (and 6)-carboxy-2',7'-dichlorofluorescein and its diacetate promoiety in the liver.
    Zamek-Gliszczynski MJ; Xiong H; Patel NJ; Turncliff RZ; Pollack GM; Brouwer KL
    J Pharmacol Exp Ther; 2003 Feb; 304(2):801-9. PubMed ID: 12538836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efflux of dietary flavonoid quercetin 4'-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2.
    Walgren RA; Karnaky KJ; Lindenmayer GE; Walle T
    J Pharmacol Exp Ther; 2000 Sep; 294(3):830-6. PubMed ID: 10945830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the structure-activity relationships of ABCC2 modulators using a screening approach.
    Wissel G; Kudryavtsev P; Ghemtio L; Tammela P; Wipf P; Yliperttula M; Finel M; Urtti A; Kidron H; Xhaard H
    Bioorg Med Chem; 2015 Jul; 23(13):3513-25. PubMed ID: 25935289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-throughput screening of excipients with a biological effect: a kinetic study on the effects of surfactants on efflux-mediated transport.
    Pollard J; Rajabi-Siahboomi A; Badhan RKS; Mohammed AR; Perrie Y
    J Pharm Pharmacol; 2019 Jun; 71(6):889-897. PubMed ID: 30784086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the involvement of P-glycoprotein and multidrug resistance-associated protein 2 in the efflux of ximelagatran and its metabolites by using short hairpin RNA knockdown in Caco-2 cells.
    Darnell M; Karlsson JE; Owen A; Hidalgo IJ; Li J; Zhang W; Andersson TB
    Drug Metab Dispos; 2010 Mar; 38(3):491-7. PubMed ID: 20023051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of multidrug resistance protein 2 (MRP2, ABCC2) in alkylating agent detoxification: MRP2 potentiates glutathione S-transferase A1-1-mediated resistance to chlorambucil cytotoxicity.
    Smitherman PK; Townsend AJ; Kute TE; Morrow CS
    J Pharmacol Exp Ther; 2004 Jan; 308(1):260-7. PubMed ID: 14569069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells.
    Lowes S; Simmons NL
    Br J Pharmacol; 2002 Mar; 135(5):1263-75. PubMed ID: 11877335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of 96 well Caco-2 cell system for increased throughput of P-gp screening in drug discovery.
    Balimane PV; Patel K; Marino A; Chong S
    Eur J Pharm Biopharm; 2004 Jul; 58(1):99-105. PubMed ID: 15207543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Species-dependent transport and modulation properties of human and mouse multidrug resistance protein 2 (MRP2/Mrp2, ABCC2/Abcc2).
    Zimmermann C; van de Wetering K; van de Steeg E; Wagenaar E; Vens C; Schinkel AH
    Drug Metab Dispos; 2008 Apr; 36(4):631-40. PubMed ID: 18180270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line Caco-2.
    Vaidyanathan JB; Walle T
    J Pharmacol Exp Ther; 2003 Nov; 307(2):745-52. PubMed ID: 12970388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy.
    Luna-Tortós C; Fedrowitz M; Löscher W
    Neuropharmacology; 2010 Jun; 58(7):1019-32. PubMed ID: 20080116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABCC1, ABCC2 and ABCC3 are implicated in the transepithelial transport of the myco-estrogen zearalenone and its major metabolites.
    Videmann B; Mazallon M; Prouillac C; Delaforge M; Lecoeur S
    Toxicol Lett; 2009 Oct; 190(2):215-23. PubMed ID: 19647055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.